In contrast, participants with systolic blood pressure under 140 millimeters of mercury — below the current cutoff for treatment — and rated with a low predicted risk of heart disease who had a ...

TCT 911: A Novel Automated and Portable Carbon Dioxide Angiographic Injector for Peripheral Endovascular Therapies in Patients at High Risk of Iodinated Contrast Media Receive the the latest news, ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...